The National Security Commission on Emerging Biotechnology (NSCEB) has released a report to Congress urging immediate action to safeguard U.S. national security in the face of rapid advancements in biotechnology. U.S. Senator Todd Young, who chairs the Commission, emphasized that Congressional action is necessary to maintain America’s global leadership in this critical area.
According to the report, the U.S. is at risk of losing its edge in biotechnology to China. Senator Young stated, “The United States is locked in a competition with China that will define the coming century. Biotechnology is the next phase in that competition.”
The report highlights concerns over U.S. reliance on China’s supply chains and suggests that biotechnology could enhance supply chain security by enabling domestic control over essential components. NSCEB Vice Chair Dr. Michelle Rozo remarked, ‘‘Technology is not inherently good or bad, but who uses it matters.”
The Commission stresses the widespread impact of biotechnology, which touches various industries beyond health, including agriculture, infrastructure, manufacturing, and defense. Senator Alex Padilla noted, “Biotechnology holds immense potential to transform numerous key sectors of our economy.”
Emerging biotechnology is poised to drive military innovations and enhance logistic and defensive capabilities, according to the report. NSCEB Commissioner Representative Stephanie Bice commented, “As emerging technologies transform the national security landscape, both the United States and our adversaries are gaining new capabilities.”
Strategic federal initiatives are vital for advancing U.S. biotechnology leadership, the Commission posits. NSCEB Commissioner Representative Ro Khanna added, “We must embolden the best and brightest in biotechnology to innovate boldly.”
The Commission has outlined six pillars for action and provided 49 recommendations to Congress, calling for strategic investments and regulatory reforms to foster biotechnology innovation. Full details can be accessed at biotech.senate.gov/final-report.
The NSCEB, established as a legislative advisory entity, aims to bolster biotechnology and biomanufacturing to enhance U.S. national security. For further information, the Commission’s comprehensive report and recommendations are available online.
